Taghi Ramazanian is a Miami, Florida based male orthopedic surgeon who is specialized in Pediatric Orthopedic. Active license number of Taghi Ramazanian is 36561 for Pediatric Orthopedic in Florida.
Taghi Ramazanian has done additional training and experience in diagnosing, treating and managing musculoskeletal problems in infants, children and adolescents. These may include limb and spine deformities (such as club foot, scoliosis); gait abnormalities (limping); bone and joint infections; broken bones.
Complete Profile:
Taghi Ramazanian speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Orthopedic - Pediatric Orthopedic
Credentials:
MD
Gender:
Male
Practice Address:
3100 Sw 62nd Ave, Miami, Florida, 33155-3009
Phone:
305-666-6511
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1225741614
NPI Enumeration Date:
30 Dec, 2022
NPI Last Update On:
30 Dec, 2022
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Taghi Ramazanian are as mentioned below.
License Number
Specialization
State
Status
36561
Pediatric Orthopedic
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
7734 Lower Gateway Loop Unit 1414, Orlando, Florida
Zip:
32827-7208
Phone Number:
571-505-2126
Fax Number:
--
Patients can reach Taghi Ramazanian at 3100 Sw 62nd Ave, Miami, Florida or can call to book an appointment on 305-666-6511. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.